A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the study drug, ACHN-490 Injection, affects the
QT interval in normal volunteers. The hypothesis is that the drug will not cause an increase
in the QT interval.
Phase:
Phase 1
Details
Lead Sponsor:
Achaogen, Inc.
Collaborator:
Department of Health and Human Services
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination